美国 · SEC FORM 4
Elanco Animal Health Inc
ELAN · NYSE · CIK 0001739104 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
7 位买方 · 7 条买入交易行 · $1.7M 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ 角色得分低 · 买入者中职位最高的是：PRESIDENT, CEO AND DIRECTOR（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
- ✓ Cluster breadth is broad · 4+ insiders
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
买方广度与集中度
Roles in the peak window: Director, EVP and CFO, GC AND CORP SEC. Concentration uses priced qualifying P lines only and does not change the saved score.
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.
信号历史
最新留档分数
- 81.4
- 81.4
- 81.2
- 81.1
- 81.1
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +0.3%
- 3M
- -8.8%
- 6M
- -0.9%
- 12M
- +12.7%
波动率与流动性
- 波动率
- 47.1%
- Beta
- —
- 平均每日成交额
- USD 142.4M
估值
- 市值
- USD 11.5B
- P/E
- —
基本面
- 利润率
- -4.9%
- ROE
- -3.5%
- 细分行业
- Drug Manufacturers—Specialty & Generic
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率, ROE · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-03 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 37,291,528
- 上期报告
- 31,809,151
- 日均成交量
- 6,054,779
- 回补天数
- 6.2
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 40,000 | USD 23.40 | USD 936,000 | SEC 申报 ↗ |
| 2026-08-18 | O'Neill Shiv | 买入 (P) | Common Stock | 3,998 | USD 23.58 | USD 94,273 | SEC 申报 ↗ |
| 2026-08-12 | Harrington Michael J | 买入 (P) | Common Stock | 5,000 | USD 21.82 | USD 109,100 | SEC 申报 ↗ |
| 2026-08-07 | VanHimbergen Robert M | 买入 (P) | Common Stock | 4,200 | USD 23.08 | USD 96,936 | SEC 申报 ↗ |
| 2026-08-07 | Herendeen Paul | 买入 (P) | Common Stock | 10,000 | USD 23.69 | USD 236,900 | SEC 申报 ↗ |
| 2026-05-15 | Simmons Jeffrey N | 买入 (P) | Common Stock | 4,971 | USD 20.09 | USD 99,867 | SEC 申报 ↗ |
| 2026-05-15 | Modi Rajeev A. | 买入 (P) | Common Stock | 4,911 | USD 20.35 | USD 99,939 | SEC 申报 ↗ |
| 2025-12-12 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 10,000 | USD 21.30 | USD 213,000 | SEC 申报 ↗ |
| 2025-12-11 | VanHimbergen Robert M | 买入 (P) | Common Stock | 6,950 | USD 21.64 | USD 150,398 | SEC 申报 ↗ |
| 2025-12-11 | Simmons Jeffrey N | 买入 (P) | Common Stock | 22,000 | USD 21.75 | USD 478,500 | SEC 申报 ↗ |
| 2025-12-11 | Modi Rajeev A. | 买入 (P) | Common Stock | 4,500 | USD 21.33 | USD 95,985 | SEC 申报 ↗ |
| 2025-03-11 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 10,000 | USD 10.20 | USD 102,000 | SEC 申报 ↗ |
| 2025-03-07 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 10,000 | USD 10.90 | USD 109,000 | SEC 申报 ↗ |
| 2025-03-05 | HOOVER R DAVID | 买入 (P) | Common Stock | 25,000 | USD 10.90 | USD 272,500 | SEC 申报 ↗ |
| 2024-08-22 | Harrington Michael J | 买入 (P) | Common Stock | 3,500 | USD 14.85 | USD 51,975 | SEC 申报 ↗ |
Form 4 申报证据
84 transaction lines in the latest 365-day window; 480 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 40,000 | USD 23.40 | USD 936,000 | SEC 申报 ↗ |
| 2026-08-18 | O'Neill Shiv | 买入 (P) | Common Stock | 3,998 | USD 23.58 | USD 94,273 | SEC 申报 ↗ |
| 2026-08-12 | Harrington Michael J | 买入 (P) | Common Stock | 5,000 | USD 21.82 | USD 109,100 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 40,000 | USD 23.40 | USD 936,000 | SEC 申报 ↗ |
| 2026-08-18 | O'Neill Shiv | 买入 (P) | Common Stock | 3,998 | USD 23.58 | USD 94,273 | SEC 申报 ↗ |
| 2026-08-12 | Harrington Michael J | 买入 (P) | Common Stock | 5,000 | USD 21.82 | USD 109,100 | SEC 申报 ↗ |
| 2026-08-07 | VanHimbergen Robert M | 买入 (P) | Common Stock | 4,200 | USD 23.08 | USD 96,936 | SEC 申报 ↗ |
| 2026-08-07 | Herendeen Paul | 买入 (P) | Common Stock | 10,000 | USD 23.69 | USD 236,900 | SEC 申报 ↗ |
| 2026-07-07 | VanHimbergen Robert M | 代扣税 (F) | Common Stock | 15,336 | USD 24.64 | USD 377,879 | SEC 申报 ↗ |
| 2026-05-21 | Scots-Knight Denise | 奖励／授予 (A) | Common Stock | 16,874 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | McDonald Kirk P | 奖励／授予 (A) | Common Stock | 16,874 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Ma Stacey | 奖励／授予 (A) | Common Stock | 16,874 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Kurzius Lawrence Erik | 奖励／授予 (A) | Common Stock | 16,874 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Kochevar Deborah Turner | 奖励／授予 (A) | Common Stock | 4,678 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Herendeen Paul | 奖励／授予 (A) | Common Stock | 16,874 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Harrington Michael J | 奖励／授予 (A) | Common Stock | 16,874 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | HOOVER R DAVID | 奖励／授予 (A) | Common Stock | 4,678 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | GARCIA ART A | 奖励／授予 (A) | Common Stock | 16,874 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-21 | Anand Kapila K | 奖励／授予 (A) | Common Stock | 16,874 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | Simmons Jeffrey N | 买入 (P) | Common Stock | 4,971 | USD 20.09 | USD 99,867 | SEC 申报 ↗ |
| 2026-05-15 | Modi Rajeev A. | 买入 (P) | Common Stock | 4,911 | USD 20.35 | USD 99,939 | SEC 申报 ↗ |
| 2026-04-01 | de Brabander Ellen | 代扣税 (F) | Common Stock | 20,288 | USD 23.12 | USD 469,059 | SEC 申报 ↗ |
| 2026-04-01 | de Brabander Ellen | 奖励／授予 (A) | Common Stock | 40,985 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-03 | de Brabander Ellen | 代扣税 (F) | Common Stock | 8,262 | USD 24.88 | USD 205,559 | SEC 申报 ↗ |
| 2026-03-03 | Simmons Jeffrey N | 代扣税 (F) | Common Stock | 37,898 | USD 24.88 | USD 942,902 | SEC 申报 ↗ |
| 2026-03-03 | O'Neill Shiv | 代扣税 (F) | Common Stock | 4,738 | USD 24.88 | USD 117,881 | SEC 申报 ↗ |
| 2026-03-03 | Modi Rajeev A. | 代扣税 (F) | Common Stock | 4,392 | USD 24.88 | USD 109,273 | SEC 申报 ↗ |
| 2026-03-03 | Meer James M | 代扣税 (F) | Common Stock | 1,389 | USD 24.88 | USD 34,558 | SEC 申报 ↗ |
| 2026-03-03 | McArdle Grace | 代扣税 (F) | Common Stock | 4,322 | USD 24.88 | USD 107,531 | SEC 申报 ↗ |
| 2026-03-03 | Kinard David S | 代扣税 (F) | Common Stock | 3,433 | USD 24.88 | USD 85,413 | SEC 申报 ↗ |
| 2026-03-03 | Correia de Simas Jose Manuel | 代扣税 (F) | Common Stock | 3,371 | USD 24.88 | USD 83,870 | SEC 申报 ↗ |
| 2026-03-03 | Cabral Ramiro Martin | 代扣税 (F) | Common Stock | 6,492 | USD 24.88 | USD 161,521 | SEC 申报 ↗ |
| 2026-03-03 | Bettington Timothy J | 代扣税 (F) | Common Stock | 4,695 | USD 24.88 | USD 116,812 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ELAN |
| CIK | 0001739104 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 480 transaction lines from 2020-02-01 to 2026-08-20 56 P purchase lines · 1 S sale lines · 423 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.